Cargando…
Geranylgeraniol (GGOH) as a Mevalonate Pathway Activator in the Rescue of Bone Cells Treated with Zoledronic Acid: An In Vitro Study
Bisphosphonates (BPs) are the keystone to treat bone disorders. Despite the great benefits of BPs, medication-related osteonecrosis of the jaw (MRONJ) arouse as a potential side effect. Nitrogen-containing BPs (N-BPs) as zoledronate (ZA) act by the inhibition of specific enzymes of the mevalonate pa...
Autores principales: | Fliefel, Riham M., Entekhabi, Saleh A., Ehrenfeld, Michael, Otto, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343170/ https://www.ncbi.nlm.nih.gov/pubmed/30728841 http://dx.doi.org/10.1155/2019/4351327 |
Ejemplares similares
-
In vitro Effect of Geranylgeraniol (GGOH) on Bisphosphonate-Induced Cytotoxicity of Oral Mucosa Cells
por: Rattanawonsakul, Krit, et al.
Publicado: (2022) -
Diverse Action of Selected Statins on Skeletal Muscle Cells—An Attempt to Explain the Protective Effect of Geranylgeraniol (GGOH) in Statin-Associated Myopathy (SAM)
por: Jaśkiewicz, Anna, et al.
Publicado: (2019) -
Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw
por: Chen, Xin, et al.
Publicado: (2021) -
The Biomedical Importance of the Missing Pathway for Farnesol and Geranylgeraniol Salvage
por: Verdaguer, Ignasi Bofill, et al.
Publicado: (2022) -
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
por: Coscia, Marta, et al.
Publicado: (2010)